Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
mtruong34's Profile
Displaying 51-100 of 505 result(s).
CYDY CytoDyn Inc
04/23/2021 4:16:55 PM
Just because a trial is ran in anot (1)
CYDY CytoDyn Inc
04/22/2021 7:48:24 PM
Grabbed this from another forum whe (1)
CYDY CytoDyn Inc
04/22/2021 11:09:37 AM
BP being called out. Writer is OM.. (3)
CYDY CytoDyn Inc
04/21/2021 9:07:58 PM
Agreed! And it also settled a linge (11)
CYDY CytoDyn Inc
04/21/2021 11:28:20 AM
An open letter from Drs. JL, Agrest (34)
CYDY CytoDyn Inc
04/20/2021 2:24:08 PM
Was this the same guy who thought h (2)
CYDY CytoDyn Inc
04/16/2021 2:41:07 PM
The patient on 60+ days ECMO that w (1)
CYDY CytoDyn Inc
03/30/2021 2:56:35 PM
The logical answer is that I have a (1)
CYDY CytoDyn Inc
03/30/2021 2:15:50 PM
Yeah I see that now. It got "refres
CYDY CytoDyn Inc
03/30/2021 2:12:04 PM
Yes. I thought Dr. Marc did an awes (2)
CYDY CytoDyn Inc
03/30/2021 1:58:17 PM
Dr. Marc Siegel talking about leron (13)
CYDY CytoDyn Inc
03/25/2021 11:54:12 PM
"The aim of this study was to descr (2)
CYDY CytoDyn Inc
03/24/2021 1:40:31 PM
One confusing thing that came out o (2)
CYDY CytoDyn Inc
03/18/2021 1:34:11 PM
Was thinking the exact same numbers
CYDY CytoDyn Inc
03/18/2021 12:03:37 PM
I know. Frustrating. I guess that's
CYDY CytoDyn Inc
03/18/2021 11:55:18 AM
I agree with your statement as well (2)
CYDY CytoDyn Inc
03/18/2021 11:25:05 AM
Craig. I am usually very confused a (6)
CYDY CytoDyn Inc
03/13/2021 11:14:36 AM
Agree. The timeline is in the evalu (4)
CYDY CytoDyn Inc
03/09/2021 8:46:04 AM
Basically I erred in putting too mu (7)
CYDY CytoDyn Inc
03/09/2021 8:29:08 AM
Basically I erred in putting too mu (1)
CYDY CytoDyn Inc
03/09/2021 1:07:29 AM
Gotcha. Thanks Cdiddy. I did listen (1)
CYDY CytoDyn Inc
03/09/2021 12:46:27 AM
Why are you so angry and how am I s (1)
CYDY CytoDyn Inc
03/08/2021 11:09:10 PM
3) Amongst all patients in mITT, th (1)
CYDY CytoDyn Inc
03/08/2021 10:56:10 PM
"Assuming just 1 was in treatment, (1)
CYDY CytoDyn Inc
03/08/2021 8:19:17 PM
RTB, you should write CYDY PR's for
CYDY CytoDyn Inc
03/08/2021 8:05:27 PM
Agreed SAF. We definitely need more (2)
CYDY CytoDyn Inc
03/08/2021 6:36:24 PM
Wow Doc580. I've made some what I v (3)
CYDY CytoDyn Inc
03/08/2021 5:51:26 PM
I don't think it would have been a (5)
CYDY CytoDyn Inc
03/06/2021 1:16:56 AM
I think if they recruit only critic
CYDY CytoDyn Inc
03/06/2021 1:09:27 AM
I think the stats guys like Tech &
CYDY CytoDyn Inc
03/06/2021 1:07:52 AM
I'm basing this on reading the PR. (1)
CYDY CytoDyn Inc
03/06/2021 12:55:45 AM
I think the wildcard is that yes, w (1)
CYDY CytoDyn Inc
03/06/2021 12:41:34 AM
"I wonder how the progression from (1)
CYDY CytoDyn Inc
03/06/2021 12:29:55 AM
Because one can use logic to deduce (2)
CYDY CytoDyn Inc
03/06/2021 12:27:10 AM
My read is that a significant numbe (1)
CYDY CytoDyn Inc
03/06/2021 12:18:47 AM
True, the full data has not been re
CYDY CytoDyn Inc
03/06/2021 12:11:56 AM
It says "this critically ill popula (1)
CYDY CytoDyn Inc
03/06/2021 12:03:05 AM
Without adequate power, that 24% re (3)
CYDY CytoDyn Inc
03/05/2021 11:55:20 PM
CT, Where do you see 4%? I'm seeing
CYDY CytoDyn Inc
03/05/2021 11:52:44 PM
I think that 28-60 day window saile (4)
CYDY CytoDyn Inc
03/05/2021 10:38:19 PM
The data on severe must have had ze (2)
CYDY CytoDyn Inc
03/05/2021 10:12:14 PM
Kabonk, do you know which IL-6 inhi (1)
CYDY CytoDyn Inc
03/05/2021 11:54:53 AM
True, but based on my observations (1)
CYDY CytoDyn Inc
03/05/2021 11:10:51 AM
There are many on the other forums (1)
CYDY CytoDyn Inc
02/26/2021 7:23:23 AM
The DSMC made the recommendation wh (2)
CYDY CytoDyn Inc
02/26/2021 7:01:05 AM
I'm basing my opinion off of knowin
CYDY CytoDyn Inc
02/26/2021 6:35:52 AM
Agreed Ken. In CYDY's haste to comp (2)
CYDY CytoDyn Inc
02/26/2021 12:39:32 AM
Looks like the same story copied ov (7)
CYDY CytoDyn Inc
02/26/2021 12:37:45 AM
Leronlimab long hauler trial in the (9)
CYDY CytoDyn Inc
02/25/2021 5:29:04 PM
I think at the time, the DSMC's rec (1)
Go to page:
  • << First
  • < Previous
  • 1
  • 2
  • Next >

Recent Articles

  • Bayview Pharmacy Discontinues Compounded Semaglutide Claims
  • Growth of the Cybersecurity Sector: Insights and Trends
  • Rising Demand and Trends in MESCBN Real-Time Data Systems
  • Explore the Advantages of Cloud Mining with RIPPLECOIN
  • Projected Growth of Wireless Mesh Network Industry by 2032
  • Global Biomarker Market Growth Projections and Insights
  • Forecast for the Application Lifecycle Management Market Growth
  • Exploring the Surge in Wireless Power Transmission by 2032
  • Benevis Champions Men's Oral Health Awareness This Month
  • Caro Holdings Unveils Cutting-Edge AI Solutions for Investors
  • Insightful Review of Rathbones Group's Stake in Assura Plc
  • Bioretec Ltd Announces Upcoming Rights Issue for Shareholders
  • WedgeHR Revolutionizes Hiring with New Strategic Investment
  • Investor Update: Treace Medical Faces Legal Scrutiny Ahead
  • Zenas BioPharma Investors Urged to Evaluate Legal Options Soon
  • Sunward Introduces New Flexible Payment Option for Members
  • Milestone Recovery Agreement Secured for Madoff Victims’ Fund
  • Unlocking Hyperconverged Solutions with Vandis and Scale
  • Insights and Updates from CF Bankshares Ahead of Annual Meeting
  • Michigan Advanced Psychiatry Expands Services with New Office
  • Exciting New Drill Findings from Power Metallic Mines
  • 5-hour ENERGY® Unveils Glow Motion: A Unique New Flavor
  • Hansson Family Expands Its Stake in Nordic American Tankers
  • Exploring the Booming RISC-V Tech Market Growth Potential
  • The Stevia Surge: How Health Trends Drive Market Growth
  • Exploring the Clinical Trial Management System Growth Factors
  • Exploring Innovations in Dairy Processing Equipment Growth
  • Exploring Cloud Mining: The Path to Passive Income Potential
  • Liza Landsman Appointed CEO of The Points Guy for Growth
  • Thumzup Media Reaches Major Growth Milestone with Advertisers
  • La-Z-Boy Incorporated Sets Date for Fiscal 2025 Earnings Call
  • Gershman Mortgage: A Legacy of 70 Years in Home Financing
  • GDS Holdings: Annual Meeting Insights and Business Updates
  • Granville Center Achieves Top Rating for Quality Care Excellence
  • Old National Bancorp Recognized for Community Impact in 2025
  • Genomma Lab Secures $1.2 Billion in Unsecured Bonds
  • Bridging the Divide: AI Adoption and Security in Enterprises
  • Lavazza and Montauk Yacht Club Unite for a Summer Delight
  • Highridge Medical Sells Bone Healing Division to Avista Partners
  • Elevex Capital Strengthens Financial Backing for Growth Plans
  • Empowering Entrepreneurs in Senior Home Care Services
  • Innovative Partnership Transforms Mental Health Care Services
  • FRUGA Celebrates a Year of Flavor and Community Impact
  • Streamlining Claims Processing with AI-Driven Solutions
  • DPX Technologies Enhances Automation for Genomic Testing Solutions
  • Hilco Global Expands Services with New Leadership Appointments
  • Dr. Rob Lamb to Lead Discussion on Advanced Refrigeration Techniques
  • Bioretec Ltd Announces Important Rights Issue for Shareholders
  • DMind-1 Revolutionizes Digital Finance with Advanced AI
  • Revolutionary Catheters Set to Change Hydrocephalus Care
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site